SCHEMBL24034733

SCHEMBL24034733

CCC1CCC(CNCC(=O)O)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SAT1 P21673 1/20 0.39
TDP1 Q9NUW8 2/20 0.39
MAPT P10636 2/20 0.34
ALDH1A1 P00352 2/20 0.34
FAAH O00519 1/20 0.34
HPGD P15428 1/20 0.34
KDM4E B2RXH2 2/20 0.34
POLB P06746 2/20 0.34
EPHX2 P34913 1/20 0.33
FFAR3 O14843 1/20 0.32
HDAC3 O15379 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
KDM5A P29375 1/20 0.32
KDM7A Q6ZMT4 1/20 0.32
KDM4C Q9H3R0 1/20 0.32
PHF8 Q9UPP1 1/20 0.32
KDM2A Q9Y2K7 1/20 0.32
MME P08473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL524625 0.89
Hydrochloric Acid SCHEMBL30478821 0.87 TDP1 (0.44) SAT1TDP1ALDH1A1HPGDKDM4E
SCHEMBL8991891 0.83 TDP1 (0.39) SAT1TDP1ALDH1A1HPGDKDM4E
SCHEMBL22043849 0.81 TDP1 (0.40) SAT1TDP1ALDH1A1HPGDKDM4E
SCHEMBL8991907 0.81 TDP1 (0.40) SAT1TDP1MAPTALDH1A1HPGD
SCHEMBL8165369 0.80 CYP2D6 (0.47) ALDH1A1HPGDKDM4EPOLBEPHX2
SCHEMBL29952972 0.80 ADH1B (0.46) TDP1ALDH1A1HPGDKDM4EPOLB
SCHEMBL20017737 0.79 TDP1 (0.43) TDP1ALDH1A1HPGDKDM5AKDM7A
SCHEMBL12958898 0.79 TDP1 (0.35) SAT1TDP1MAPTALDH1A1HPGD
SCHEMBL157039 0.78 EPHX1 (0.50) ALDH1A1HPGDKDM4EPOLBEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210352945-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF HERCULES CAPITAL, INC. 2021-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210352945-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF OSTC, FUT5, FUT6 SAT1 2833/4885TDP1 4665/4885MAPT 3440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.